Nifty 50
- Dr. Reddy's Labs₹1,229.4032.40 (2.71%)
- Apollo Hospitals₹7,775-252.50 (-3.15%)
- Bajaj Auto₹10,034256.00 (2.62%)
- ITC₹257.90-8.10 (-3.05%)
- Tata Motors PV₹284.454.55 (1.63%)
- Tech Mahindra₹1,471-43.10 (-2.85%)
- Bharat Electronics₹373.905.75 (1.56%)
- L&T₹3,627.50-75.80 (-2.05%)
- BSE₹3,330.2043.00 (1.31%)
- Max Healthcare₹865.95-17.85 (-2.02%)
- Cipla₹1,317.4016.40 (1.26%)
- Hindalco Industries₹882.50-17.85 (-1.98%)
- Eicher Motors₹7,11969.00 (0.98%)
- Hindustan Unilever₹1,820.70-36.00 (-1.94%)
- Mahindra & Mahindra₹2,81316.80 (0.60%)
- SBI₹941-18.10 (-1.89%)
- Kotak Mahindra Bank₹443.402.40 (0.54%)
- Coal India₹404.80-6.75 (-1.64%)
- HCL Technologies₹1,2236.30 (0.52%)
- Bharti Airtel₹1,778.70-26.40 (-1.46%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Tata Elxsi Signs Healthcare Technology MoU; Shares Rise 0.54%
Authored By HDFC SKY | Published at: Jul 27, 2026 02:02 PM IST
Tata Elxsi partnered with SCTIMST to jointly develop next-generation healthcare and medical technologies, while shares gained 0.54%.

Open Free Demat Account
Open Free Demat Account
Mumbai July, 27: Tata Elxsi has entered into a strategic partnership with the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) to jointly develop next-generation healthcare solutions, bringing clinical research and product engineering capabilities under a common development framework.
The two organisations signed a Memorandum of Understanding at SCTIMST in Thiruvananthapuram, according to an exchange disclosure dated July 27, 2026. SCTIMST is an Institution of National Importance under the Department of Science and Technology, Government of India.
The partnership will combine SCTIMST’s expertise in cardiovascular sciences, neurosciences, biotechnology and clinical sciences with Tata Elxsi’s capabilities across product engineering, design, artificial intelligence and digital technologies.
The scope is broad. Both sides intend to explore diagnostics, medical imaging, digital health, biomedical engineering and medical devices, with solutions aimed at Indian as well as international healthcare markets.
Importantly, the arrangement goes beyond a conventional research tie-up. Tata Elxsi said the collaboration will bring clinicians, specialist researchers, laboratories, prototyping infrastructure and engineering teams into a common development ecosystem. That could allow MedTech companies to move from early-stage concepts through development and validation more efficiently.
The MoU also provides a framework for joint research, academic engagement, technology development and intellectual property creation through project-specific collaborations. Initial work will focus on identifying a select set of opportunities suitable for joint development.
Stock Market Snapshot
Tata Elxsi share price was trading at ₹3,557.10 as of 1:31 PM IST on July 27, 2026, up ₹19.10, or 0.54%, according to exchange market data.
The stock saw sizeable swings during the first half of the session. After trading below the previous reference level during early dealings, it climbed sharply after 10 AM and approached ₹3,580.
Some of those gains were subsequently erased, with the stock briefly moving towards ₹3,530 around 10:35 AM. It recovered again and spent much of the period from late morning to early afternoon in positive territory, largely between ₹3,555 and ₹3,570.
At the latest available timestamp, shares remained moderately higher at ₹3,557.10.

Partnership Builds On Tata Elxsi’s Healthcare Engineering Business
Tata Elxsi is a design and technology services company serving industries including healthcare, automotive, media and telecom, and consumer electronics. Its healthcare and life sciences practice works across medical devices, pharmaceuticals, biotechnology, healthcare providers and digital health.
The company’s healthcare capabilities cover product engineering and design, regulatory compliance, software development, AI, cloud and data technologies. The SCTIMST partnership adds direct access to specialist clinical and biomedical research capabilities, potentially strengthening the development and validation stages of healthcare products.
SCTIMST, based in Thiruvananthapuram, operates an ecosystem comprising a super-speciality hospital, Biomedical Technology Wing and Achutha Menon Centre for Health Science Studies.
For Tata Elxsi, the collaboration creates a formal route to combine its engineering expertise with clinical and scientific research at the development stage. No financial consideration or specific revenue opportunity from the MoU was disclosed.
Conclusion
The SCTIMST agreement expands Tata Elxsi’s healthcare technology ecosystem without attaching an immediate contract value to the partnership. Its significance lies in the joint development framework covering medical devices, diagnostics, imaging, digital health and AI-enabled healthcare technologies.
The stock was positive during the session, with Tata Elxsi shares trading 0.54% higher at ₹3,557.10 as of 1:31 PM IST on July 27, 2026.
Source:
https://www.nseindia.com/get-quote/equity/TATAELXSI/Tata-Elxsi-Limited
https://nsearchives.nseindia.com/corporate/TELNSE_27072026120234_PressRelease_27072026.pdf
Disclaimer
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations
Disclaimer
At HDFC SKY*, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations.
HDFC SKY from HDFC Securities, one of most trusted trading platforms in India, has been recognized with the *Next-Gen Digi Content Awards 2025-26.
More TATAELXSI News
Open Free Demat Account
Open Free Demat Account
₹3,257





By signing up I certify terms, conditions & privacy policy

Join Us
Add as preferred source on Google








